Pharma and Biotech Market Access Trends: A Look Back at 2016
The increasing developmental costs, shifting influences between stakeholders, and growing pharmaceutical competition are just some of the factors that are reshaping pharma’s market access schemes. With an environment that is becoming increasingly complex, the pricing, reimbursement and market access landscape is likely to continue to change.At the start of 2016, the industry predicted many market access trends. As we come to the end of the year, let us look at the market access trends predicted...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.